Page 10 - Labatt Brain Tumour Research Centre Annual Report 2022 to 2023
P. 10
LECTURESHIPS
Lectureships
24th Annual Labatt BTRC
Academic Lectureship
The 24th Labatt Lectureship featured the lecture titled “Findings from the Immune Topographical Atlas and Implications for CNS Oncology Immunotherapy” by Dr. Amy Heimberger, PhD. Dr. Heimberger is the Jean Malnati Miller Professor of Neurological
10 IMAGINE 2021-22
Virtual event with Dr. Amy Heimberger
Surgery, Vice-Chair for Research in the Department of Neurological Surgery at Northwestern University and Scientific Director of The Malnati Brain Tumor Institute at the Robert H. Lurie Comprehensive Cancer Center. Her research program focuses on immune therapeutic strategies for patients with Central Nervous System (CNS) malignancies and she studies tumour-mediated mechanisms of immune suppression. She has been intricately involved in a wide variety of bench- to-bedside immune therapeutics, including those that were developed in her laboratory and arising from her own patents. Dr. Heimberger has been the lead on multiple clinical trials including the advocation for window-of-opportunity designs to evaluate the CNS tumour microenvironment.
